paclitaxel has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottesman, MM; Malech, HL; Nunoi, H; Sato, S; Sugimoto, Y; Suzuki, M; Tsukahara, S; Tsuruo, T | 1 |
1 other study(ies) available for paclitaxel and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Topics: Animals; Antigens, CD34; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Cell Separation; Flow Cytometry; Gene Transfer Techniques; Genetic Linkage; Genetic Therapy; Genetic Vectors; Granulomatous Disease, Chronic; Hematopoietic Stem Cells; Humans; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Models, Genetic; NADPH Oxidase 2; NADPH Oxidases; NIH 3T3 Cells; Paclitaxel; Phenotype; Retroviridae; Superoxides; Time Factors; Transgenes; Vincristine; X Chromosome | 2003 |